haloperidol and haloperidol decanoate

haloperidol has been researched along with haloperidol decanoate in 178 studies

Research

Studies (178)

Timeframe	Studies, this research(%)	All Research%
pre-1990	52 (29.21)	18.7374
1990's	65 (36.52)	18.2507
2000's	25 (14.04)	29.6817
2010's	34 (19.10)	24.3611
2020's	2 (1.12)	2.80

Authors

Authors	Studies
Gmeiner, P; Hübner, H; Löber, S; Salama, I	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
McHugh, TP	1
Hay, J	1
Haufe, C; Knorr, W; Schellenberg, R; Schwarz, A	1
Hughes, GW; Perry, HM	1
Reinke, M; Wiesert, KN	1
Dysken, MW; Holden, L; Johnson, SB; Kim, SW; Skare, S; Thomsyck, L; Vatassery, G	1
Koskinen, T; Mølbjerg, C; Nerdrum, T; Pedersen, V; Thelander, S; Wistedt, B	1
Youssef, HA	2
Eklund, K; Forsman, A	1
Edwards, JG; Fukushima, Y; Goldie, A; Kaneko, S; Sato, T	1
Hashimoto, M; Matsunaga, Y; Miyazaki, H; Oh-e, Y	1
Cookson, JC	1
Altamura, CA; Colacurcio, F; De Novellis, F; Mauri, MC; Moro, AR	1
Emmett, MR; Kim, HS; Petrack, B; Rao, TS; Wood, PL	1
Kalugina, LI; Kopeĭko, GI; Kravchenko, NE; Mirzoian, MG; Ushakov, IuV	1
Egan, TM; Grimmig, JE; Hamann, GL; Wells, BG	1
Cahard, C; Conquy, T; Rop, PP; Viala, A	1
Christodoulou, GN; Kontaxakis, VP; Vaidakis, NM; Valergaki, HC	1
Johansson, P	1
McCreadie, RG; Whitehead, A; Wiles, DH	1
Davis, CM; Ereshefsky, L; Lyman, RC; Saklad, SR; Toney, G; Tran-Johnson, T	1
Annable, L; Campbell, W; Chouinard, G	1
Alda, M; Dufkova, D; Kristofikova, Z; Pavlovsky, P	1
Zapletálek, M; Zbytovský, J	2
Davis, CM; Froemming, JS; Jann, MW; Lam, YW	1
Nasser, J; Thomas, B	1
Akiyama, K; Otsuki, S; Sato, M; Yamada, N	1
Lowe, MR	1
Brizuela, A; Caruso, S; Cuervo, L; Marchant, N	1
Knudsen, P	1
Kane, JM	1
Bollen, J; De Cuyper, H; van Praag, HM; Verstraeten, D	1
Kissling, W; Möller, HJ	1
Alvarez, JV; Li Gambi, M	1
James, WA; Pary, R; Tobias, CR; Turns, DM	1
Evans, RL; Hemstrom, CA; Lobeck, FG	1
Dabrowski, G; Graveleau, P; Grenet, D; Hurel, D; Legras, A; Loirat, P	1
Rueda-Vasquez, E	1
Clarke, DJ; Ford, R	1
Jefferson, JW	1
Ellerman, LA	1
McCreadie, RG; McKane, JP; Robinson, AD; Stirling, GS; Wiles, DH	1
Achim, A; Lizondo, E; Nayak, R; Schwartz, G; Suranyi-Cadotte, B; Thavundayil, JX; Vasavan Nair, NP	1
Loew, MR	1
Beresford, R; Ward, A	1
Wistedt, B	1
Cookson, JC; Gribbon, D; Kennedy, NM	1
Gelders, YG	1
Leff, JP; Tress, KH	1
Batchelor, DH; Lowe, MR	1
Batchelor, DH; Read, SG	1
Hashimoto, M; Matsunaga, Y; Miyazaki, H; Nakanishi, Y; Nambu, K; Oh-e, Y	1
Hashimoto, M; Matsunaga, Y; Miyazaki, H; Nambu, K; Oh-e, Y	1
Eberhard, G; Hellbom, E	1
Fujiwara, Y; Harada, T; Kashihara, K; Ogawa, T; Otsuki, S; Sato, M	1
Elderson, A; Verhoeven, WM; Westenberg, HG	1
Kissling, W; Krueger, R; Möller, HJ; Trenk, D; Walter, K; Wittmann, B	1
Agnoli, A; Casacchia, M; Falaschi, P; Meco, G; Petrini, P; Rocco, A; Rosa, M	1
Asano, K; Kadokawa, T; Karasawa, T; Ochi, Y; Oka, M; Terauchi, Y	1
Roncoroni, D	1
Mori, A	1
arap Mengech, HN; Wazome, EG	1
Annable, L; Boisvert, D; Bradwejn, J; Campbell, W; Chouinard, G	1
Alexandre, JY; Clerc, G; Darondel, A; Delaunay, J; Delteil, P; Leger, JM; Lemperiere, T; Malauzat, D; Raynaud, J; Ropert, R	1
Harada, T; Kashihara, K; Sato, M	1
Buttinelli, C; Ciani, S; Fiume, S; Lenzi, GL; Paolucci, S	1
Fernando, J; Jones, GG; Krishna Raju, R; Stanley, RO	1
Gordin, A; Lamminsivu, U; Salo, H; Viukari, M	1
Aerts, TJ; Gelders, YG; Heykants, JJ; Reyntigens, AJ; Woestenborghs, RJ	1
Aerts, TJ; Ash, CW; Gelders, YG; Reyntijens, AJ	1
Brown, ES; Lambert, MT	1
Jaffe, E; Reider, R; Sharif, Z; Trémeau, F	1
Amico, E; Goff, DC; Hubbard, JW; Midha, KK; Sarid-Segal, O	1
Freudenreich, O; McEvoy, JP	1
Egan, MF; Hyde, TM; Kleinman, JE; Weinberger, DR; Wing, LL; Wyatt, RJ	1
Guttmacher, LB; Maharaj, K; Moeller, R	1
Kurachi, M; Murata, M; Shibata, R; Tanii, Y	1
Maj, M; Martino, M; Monteleone, P; Piccolo, A	1
Bertilsson, L; Dahl, ML; Farde, L; Halldin, C; Nyberg, S	1
Dencker, SJ; Giös, I; Mårtensson, E; Nordén, T; Nyberg, G; Persson, R; Roman, G; Stockman, O; Svärd, KO	1
Agenet, C; Barges-Bertocchio, MH; Levron, JC; Pupeschi, G	1
Komen, BJ; Thieme, RE; van der Hoeven, RT; van Weringh, G; Vos, T	1
Baruah, S; Sherman, A; Waziri, R	1
Anderson, C; Ereshefsky, L; Saklad, SR; Seidel, D; Toney, G	1
Dimpfel, W; Milch, W; Schellenberg, R; Schober, F; Schwarz, A	1
Hagino, H; Kurachi, M; Kurachi, T; Kurata, K; Murata, M; Shibata, R; Tanii, Y; Yasui, S	1
Richardson, NR; Roberts, DC; Smith, AM	1
Brauzer, B; Casey, DE; Davis, JM; Gierl, B; Hassan, M; Kane, JM; Marder, SR; Schooler, N	1
Cesková, E; Rysánek, R; Svestka, J	1
Zbytovský, J	2
Schellenberg, R; Schwarz, A	1
Beckmann, H; Fritze, J; Riederer, P; Wodarz, N	1
Chang, WH; Chen, LC; Chien, CP; Hu, WH; Jann, MW; Juang, DJ; Lam, YF; Lin, SK; Yang, CH	1
Gavin, KT; Harrison, N; O'Boyle, KM	1
Chang, WH; Chen, LC; Chien, CP; Hu, WH; Jann, MW; Juang, DJ; Lam, YW; Lin, SK; Yang, CH	1
Chang, WH; Chen, LC; Jann, MW; Juang, DJ; Lane, HY; Lin, SK; Yang, CH	1
Chang, WH; Jann, MW; Lin, HN; Piao-Chien, C; Wei, FC	2
Aymard, N; Caroli, F; Stein, I; Viala, A	1
Heinz, P	1
Haavisto, E; Huttunen, MO; Nyholm, R; Pitkänen, M; Raitasuo, V; Romanov, M; Tuhkanen, H	1
Levander, S; Tuninger, E	1
Benati, F; Cesario, V; Lazzarin, M	1
Arbuthnott, GW; Docter, GJ; Ingham, CA; Meredith, GE; Mijnster, MJ	1
Dhopesh, V; Gamble, G; Maany, I; Macfadden, A	1
Albus, M; Mager, T; Oertel, WH; Scherer, J; Schwarz, J; Tatsch, K	1
Farde, L; Halldin, C; Nyberg, S	1
Belpaire, FM; Pan, L; Rosseel, MT	1
Kurachi, M; Kurachi, T; Murata, M; Sun, YJ; Suzuki, M	1
Freccero-Rosman, K; Levander, S; Ohlsson, T; Rosén, I; Ryding, E; Sjöholm, H; Tuninger, E	1
Baca, SM; Egan, MF; Hamid, EH; Hyde, TM	1
Conley, RR; Kelly, DL; Love, RC; Moore, DB; Sherr, JD	1
Belpaire, FM; Berlo, JA; De Schepper, N; Pan, L; Rosseel, MT; Vander Stichele, R	1
David, A; Quraishi, S	1
Alessi, N; Alkhouri, I; Fluent, T; Quinlan, P; Williams, K	1
Averill, P; Hays, JR; Varner, RV; Wagner, AL	1
Andrén, PE; Gunne, L; Klintenberg, R	1
Brauzer, B; Casey, D; Conley, R; Davis, JM; Kane, JM; Marder, S; Mintz, J; Schooler, N	1
Chengappa, KN; Jeste, DV; Mamo, DC; Reddy, RR; Sweet, RA	1
Kapur, S; Nobrega, JN; Remington, G; Turrone, P	1
Girard, F; Ikehira, H; Obata, T; Okubo, Y; Sassa, T; Suhara, T; Tanada, S	1
Eggan, SM; Hashimoto, T; Lewis, DA; Mirnics, K; Pierri, JN; Sampson, AR; Sun, Z; Volk, DW	1
Becker, T; Kopf, A; Köster, J; Krömker, H; Schulz, A	1
Agrawal, SM; McCullumsmith, RE; Meador-Woodruff, JH; Stincic, TL	1
Aamo, TO; Andreassen, OA; Beal, MF; Ferrante, RJ; Jørgensen, HA	1
Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M	1
Baldi, A; Becú-Villalobos, D; Cristina, C; Díaz-Torga, G; Góngora, A; Low, MJ; Rubinstein, M	1
Glick, ID; Marder, SR	1
Buschman, HP; Hariz, M; Kölling, P; Lenders, MW; Steur, EN; Vergouwen, MD	1
Adetunji, B; Basil, B; Mathews, M; Osinowo, T; Williams, A	1
McEvoy, JP	1
Ascher-Svanum, H; Faries, D; Marder, SR; Montgomery, W; Shi, L; Zhu, B	1
de Magalhães, L; Hernandes, MS; Troncone, LR	1
Lorenz, RA; Weinstein, B	1
Kantrowitz, JT; Srihari, VH; Tek, C	1
Betuing, S; Brouillet, E; Caboche, J; Charvin, D; Déglon, N; Deyts, C; Luthi-Carter, R; Pagès, C; Perrin, V; Régulier, E; Roze, E	1
Cardoso, L; Galera, SA	1
Barcelos, RC; Benvegnú, DM; Boufleur, N; Bürger, ME; Emanuelli, T; Müller, LG; Pase, C; Reckziegel, P	1
Kubakawa, T; Niimura, H	1
Bymaster, F; Duman, RS; Girgenti, MJ; Newton, SS; Nisenbaum, LK; Terwilliger, R	1
Cerimele, JM; Jutras-Aswad, D; Stern, AP	1
Citrome, L; Jaffe, A; Levine, J	1
Brahm, NC; Washington, NB	1
Bhattacharya, A; Das, S; Hazarika, S; Nath, K; Roy, D; Saddichha, S	1
Covell, NH; Essock, SM; Jackson, CT; McEvoy, JP; Rojas, IA; Schooler, NR; Stroup, TS	1
Gen, K; Suzuki, H	1
Drummond, JB; Haroutunian, V; Meador-Woodruff, JH; Simmons, M	1
Bellaaj, R; Bouguerra, C; Gallali, S; Mehdi, F; Oumaya, A; Sejil, I	1
Den, R; Mimura, M; Sakurai, H; Suzuki, T; Tsutsumi, C; Uchida, H; Uchida, T	1
Bošković, M; Grabnar, I; Kores Plesničar, B; Terzič, T; Vovk, T	1
Beasley, M; D'Mello, DA; Getzen, H	1
Bø, CN; Einarson, TR; Hemels, ME; Jensen, R; Piwko, C; Pudas, H; Vicente, C; Zilbershtein, R	1
Bialko, CS; Cassidy, KA; Fuentes-Casiano, E; Hahn, DY; Levin, J; Ramirez, LF; Sajatovic, M; Tatsuoka, C; Williams, TD	1
Haroutunian, V; Meador-Woodruff, JH; Pinner, AL	1
Busanello, A; de Freitas, CM; de Moraes Reis, E; Fachinetto, R; Ferreira, J; Figueira, FH; Leal, CQ; Mello, CF; Röpke, J; Villarinho, JG	1
Goff, DC	1
Buckley, PF; Byerly, M; Dominik, R; Hamer, RM; Lamberti, JS; McEvoy, JP; Ray, N; Rosenheck, RA; Stroup, TS; Swartz, MS; Wilkins, TM	1
Bošković, M; Grabnar, I; Koprivšek, J; Plesničar, BK; Vovk, T	1
Chan, CL; Guo, LT; Ng, SM; Ran, MS; Xiang, MZ	1
Williams, JB	1
Haroutunian, V; Kippe, JM; Meador-Woodruff, JH; Mueller, TM	1
Gedzior, JS; Matthew, BJ	1
Caton, M; Newman, WJ; Scangos, KW	1
Byerly, MJ; Hamer, RM; Leslie, DL; Li, Y; Lin, H; McEvoy, JP; Rosenheck, RA; Sint, KJ; Stroup, TS; Swartz, MS	1
Ide, GD; Khan, AY; Ovais, M; Salaria, S	1
De Vos, C; Decuypere, F; Denee, TR; Geerts, P; Lamotte, M; Malfait, B; Mulder, CL; Sermon, J	1
Dekkers, BGJ; Eck, RJ; Ter Maaten, JC; Touw, DJ	1
Tagne Nouemssi, AB	1
Bareis, NA; McEvoy, JP; Rosenheck, RA; Stroup, TS; Swartz, MS	1
Ansolabehere, X; Guillon, P; Harmand, S	1
Apramian, A; Kajani, R; Liu, A; Ubhayakar, N; Vega, A; Xu, P	1
Bernal, JA; Bez, Y; Coffey, BJ; Zaydlin, M	1

Reviews

11 review(s) available for haloperidol and haloperidol decanoate

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Pharmacokinetics of haloperidol. Clinical pharmacokinetics, 1989, Volume: 17, Issue:6 Topics: Drug Interactions; Haloperidol; Humans	1989
Haloperidol decanoate: a depot antipsychotic. Drug intelligence & clinical pharmacy, 1988, Volume: 22, Issue:4 Topics: Antipsychotic Agents; Delayed-Action Preparations; Haloperidol; Humans	1988
Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis. Drugs, 1987, Volume: 33, Issue:1 Topics: Haloperidol; Humans; Psychotic Disorders	1987
[Recent advances in clinical psychopharmacology]. Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology, 1984, Volume: 4, Issue:3 Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzamides; Carbamazepine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Kinetics; Lithium; Psychopharmacology; Schizophrenia	1984
Dose response of prophylactic antipsychotics. The Journal of clinical psychiatry, 1993, Volume: 54 Suppl Topics: Administration, Oral; Aftercare; Antipsychotic Agents; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Humans; Patient Compliance; Psychotherapy; Recurrence; Schizophrenia; Schizophrenic Psychology	1993
Depot haloperidol decanoate for schizophrenia. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Antipsychotic Agents; Delayed-Action Preparations; Haloperidol; Humans; Schizophrenia	2000
[Life threatening neuroleptic malignant syndrome due to olanzapine]. Psychiatrische Praxis, 2003, Volume: 30, Issue:5 Topics: Antipsychotic Agents; Benzodiazepines; Critical Care; Electroconvulsive Therapy; Female; Haloperidol; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Pirenzepine; Psychotic Disorders; Recurrence	2003
Risks versus benefits of different types of long-acting injectable antipsychotics. The Journal of clinical psychiatry, 2006, Volume: 67 Suppl 5 Topics: Administration, Oral; Antipsychotic Agents; Fluphenazine; Haloperidol; Health Care Costs; Humans; Injections, Intramuscular; Microspheres; Quality of Life; Risk Assessment; Risperidone; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Refusal	2006
[Psychiatric care for patients with addiction of amphetamine, CNS stimulant]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2009, Volume: 111, Issue:7 Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Antipsychotic Agents; Crime; Female; Haloperidol; Humans; Japan; Male; Middle Aged; Substance Abuse Detection	2009
Depot antipsychotics: Where do we stand? Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2016, Volume: 28, Issue:4 Topics: Antipsychotic Agents; Haloperidol; Hospitalization; Humans; Medication Adherence; Paliperidone Palmitate; Schizophrenia	2016

Trials

38 trial(s) available for haloperidol and haloperidol decanoate

Article	Year
Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study. Acta psychiatrica Scandinavica, 1991, Volume: 84, Issue:1 Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Double-Blind Method; Female; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sex Factors	1991
Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo. Clinical neuropharmacology, 1991, Volume: 14 Suppl 2 Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Radioimmunoassay; Recurrence; Schizophrenia	1991
Side effects during long-term treatment with depot antipsychotic medication. Clinical neuropharmacology, 1991, Volume: 14 Suppl 2 Topics: Akathisia, Drug-Induced; Delayed-Action Preparations; Double-Blind Method; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Parkinson Disease, Secondary; Psychomotor Agitation; Recurrence; Schizophrenia	1991
[Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1990, Volume: 90, Issue:7 Topics: Antipsychotic Agents; Cost-Benefit Analysis; Fluphenazine; Haloperidol; Humans; Remission Induction; Schizophrenia	1990
Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia. Psychopharmacology, 1990, Volume: 101, Issue:2 Topics: Adult; Aged; Biological Availability; Double-Blind Method; Female; Fluphenazine; Half-Life; Haloperidol; Humans; Male; Middle Aged; Prolactin; Radioimmunoassay; Schizophrenia	1990
A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia. Journal of clinical psychopharmacology, 1989, Volume: 9, Issue:4 Topics: Adolescent; Adult; Aged; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1989
Dosage strategies with long-acting injectable neuroleptics, including haloperidol decanoate. Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:1 Suppl Topics: Antipsychotic Agents; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule; Haloperidol; Humans; Injections; Schizophrenia	1986
[Evaluation of the efficacy of haloperidol decanoate]. Acta psiquiatrica y psicologica de America latina, 1986, Volume: 32, Issue:3 Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Psychotic Disorders	1986
[Open clinical trial with haloperidol decanoate in patients with psychotic disorders]. Acta psiquiatrica y psicologica de America latina, 1987, Volume: 33, Issue:2 Topics: Clinical Trials as Topic; Female; Haloperidol; Humans; Male; Psychotic Disorders	1987
Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients. The British journal of psychiatry : the journal of mental science, 1987, Volume: 151 Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Random Allocation; Schizophrenia	1987
A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence. Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:1 Suppl Topics: Administration, Oral; Adult; Chronic Disease; Clinical Trials as Topic; Female; Haloperidol; Humans; Injections, Intramuscular; Kinetics; Male; Middle Aged; Schizophrenia	1986
Rapid cycling disorders and the role of combined lithium and haloperidol decanoate. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1986, Volume: 31, Issue:9 Topics: Bipolar Disorder; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Haloperidol; Humans; Lithium	1986
A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients. International clinical psychopharmacology, 1986, Volume: 1 Suppl 1 Topics: Adult; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia	1986
Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate. International clinical psychopharmacology, 1986, Volume: 1 Suppl 1 Topics: Adult; Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prolactin; Schizophrenia	1986
Haloperidol decanoate and flupenthixol decanoate in schizophrenia. A long-term double-blind cross-over comparison. Acta psychiatrica Scandinavica, 1986, Volume: 74, Issue:3 Topics: Adult; Double-Blind Method; Female; Flupenthixol; Haloperidol; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes	1986
Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention. Pharmacopsychiatry, 1985, Volume: 18, Issue:3 Topics: Adult; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia	1985
[Haloperidol decanoate in replacing combinations of antipsychotic agents in the treatment of chronic schizophrenics]. Acta psiquiatrica y psicologica de America latina, 1984, Volume: 30, Issue:4 Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Schizophrenia, Paranoid	1984
A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia. Psychopharmacology bulletin, 1984,Winter, Volume: 20, Issue:1 Topics: Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Schizophrenia	1984
Tolerance and serum levels of haloperidol during parenteral and oral haloperidol treatment in geriatric patients. Acta psychiatrica Scandinavica, 1982, Volume: 65, Issue:4 Topics: Administration, Oral; Aged; Delayed-Action Preparations; Dementia; Drug Tolerance; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Psychiatric Status Rating Scales	1982
A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia. Psychopharmacology, 1995, Volume: 117, Issue:4 Topics: Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluphenazine; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1995
A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients. Psychopharmacology, 1994, Volume: 114, Issue:1 Topics: Adult; Antipsychotic Agents; Chromatography, High Pressure Liquid; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Perphenazine; Prolactin; Schizophrenia; Schizophrenic Psychology; Spectrophotometry, Ultraviolet	1994
Comparative bioavailability study of two haloperidol decanoate containing products. Pharmacy world & science : PWS, 1994, Dec-02, Volume: 16, Issue:6 Topics: Adult; Antipsychotic Agents; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Female; Half-Life; Haloperidol; Humans; Male; Middle Aged; Therapeutic Equivalency	1994
A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:7 Topics: Administration, Oral; Adult; Antipsychotic Agents; Chronic Disease; Drug Administration Schedule; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Patient Compliance; Prospective Studies; Recurrence; Schizophrenia; Treatment Outcome	1996
Pharmacoclinical correlations in schizophrenic patients treated with haloperidol decanoate: clinical evaluations, concentrations of plasma and red blood cell haloperidol and its reduced metabolite, and plasma homovanillic acid. Progress in neuro-psychopharmacology & biological psychiatry, 1995, Volume: 19, Issue:7 Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Erythrocytes; Female; Haloperidol; Homovanillic Acid; Humans; Kinetics; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Time Factors	1995
Low- and standard-dose depot haloperidol combined with targeted oral neuroleptics. Psychiatric services (Washington, D.C.), 1996, Volume: 47, Issue:1 Topics: Administration, Oral; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Neurologic Examination; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1996
D2-dopamine-receptor occupancy during treatment with haloperidol decanoate. European archives of psychiatry and clinical neuroscience, 1997, Volume: 247, Issue:2 Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Receptors, Dopamine D2; Schizophrenia	1997
A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia. The American journal of psychiatry, 2002, Volume: 159, Issue:4 Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	2002
19F-magnetic resonance spectroscopy and chemical shift imaging for schizophrenic patients using haloperidol decanoate. Psychiatry and clinical neurosciences, 2002, Volume: 56, Issue:6 Topics: Adult; Antipsychotic Agents; Female; Fluorine; Haloperidol; Humans; Injections, Intramuscular; Isotopes; Magnetic Resonance Spectroscopy; Male; Middle Aged; Schizophrenia	2002
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics. International clinical psychopharmacology, 2004, Volume: 19, Issue:4 Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia	2004
Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:5 Topics: Administration, Oral; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazepines; Female; Haloperidol; Humans; Incidence; Injections, Intramuscular; Long-Term Care; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Survival Analysis; Treatment Outcome	2005
Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:5 Topics: Antipsychotic Agents; Connecticut; Delayed-Action Preparations; Drug Substitution; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Hyperprolactinemia; Injections; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Microspheres; Middle Aged; Patient Compliance; Proportional Hazards Models; Risperidone; Schizophrenia; Weight Gain	2012
The influence of switching from haloperidol decanoate depot to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia. Human psychopharmacology, 2012, Volume: 27, Issue:5 Topics: Adult; Aged; Antipsychotic Agents; Cognition Disorders; Delayed-Action Preparations; Diagnosis, Computer-Assisted; Executive Function; Female; Haloperidol; Humans; Injections; Male; Memory; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Time Factors; Treatment Outcome	2012
Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:12 Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Delayed-Action Preparations; Female; Haloperidol; Hospitalization; Humans; Ill-Housed Persons; Injections, Intramuscular; Male; Medication Adherence; Prospective Studies; Psychiatric Status Rating Scales; Psychological Techniques; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; United States	2013
Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial. JAMA, 2014, May-21, Volume: 311, Issue:19 Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Double-Blind Method; Female; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Schizophrenia; Treatment Failure; Treatment Outcome; Weight Gain	2014
Vitamin E and essential polyunsaturated fatty acids supplementation in schizophrenia patients treated with haloperidol. Nutritional neuroscience, 2016, Volume: 19, Issue:4 Topics: Administration, Oral; Adult; Antioxidants; Antipsychotic Agents; Biomarkers; Combined Modality Therapy; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Dietary Supplements; Double-Blind Method; Fatty Acids, Essential; Fatty Acids, Omega-3; Haloperidol; Humans; Male; Middle Aged; Oleic Acid; Oxidative Stress; Pilot Projects; Psychiatric Status Rating Scales; Schizophrenia; Vitamin E	2016
The effectiveness of psychoeducational family intervention for patients with schizophrenia in a 14-year follow-up study in a Chinese rural area. Psychological medicine, 2015, Volume: 45, Issue:10 Topics: Adult; Aged; Analysis of Variance; Antipsychotic Agents; China; Family; Female; Follow-Up Studies; Haloperidol; Humans; Interviews as Topic; Male; Middle Aged; Patient Acceptance of Health Care; Patient Education as Topic; Rural Population; Schizophrenia; Schizophrenic Psychology	2015
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia. Psychiatric services (Washington, D.C.), 2016, 10-01, Volume: 67, Issue:10 Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cost-Benefit Analysis; Delayed-Action Preparations; Double-Blind Method; Female; Haloperidol; Humans; Injections; Male; Middle Aged; Outcome Assessment, Health Care; Paliperidone Palmitate; Patient Acceptance of Health Care; Psychotic Disorders; Quality-Adjusted Life Years; Schizophrenia; United States; Young Adult	2016
Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications. The Journal of clinical psychiatry, 2018, 11-27, Volume: 80, Issue:1 Topics: Adolescent; Adult; Affective Disorders, Psychotic; Age Factors; Aged; Antipsychotic Agents; Delayed-Action Preparations; Female; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Paliperidone Palmitate; Progression-Free Survival; Schizophrenia; Treatment Failure; Young Adult	2018

Other Studies

129 other study(ies) available for haloperidol and haloperidol decanoate

Article	Year
Synthesis and binding profile of haloperidol-based bivalent ligands targeting dopamine D(2)-like receptors. Bioorganic & medicinal chemistry letters, 2014, Aug-15, Volume: 24, Issue:16 Topics: Binding Sites; Dose-Response Relationship, Drug; Haloperidol; Humans; Ligands; Molecular Structure; Receptors, Dopamine D2; Structure-Activity Relationship	2014
Neuroleptic malignant syndrome. Journal of the South Carolina Medical Association (1975), 1992, Volume: 88, Issue:6 Topics: Adult; Antipsychotic Agents; Diagnosis, Differential; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome	1992
Injection site reactions. The Journal of clinical psychiatry, 1992, Volume: 53, Issue:7 Topics: Antipsychotic Agents; Delayed-Action Preparations; Drug Eruptions; Haloperidol; Humans; Hypersensitivity, Delayed; Injections, Intramuscular; Survival Analysis	1992
EEG-brain mapping. A method to optimize therapy in schizophrenics using absolute power and center frequency values. Schizophrenia research, 1992, Volume: 8, Issue:1 Topics: Adult; Alpha Rhythm; Antipsychotic Agents; Brain Mapping; Cerebral Cortex; Dominance, Cerebral; Dose-Response Relationship, Drug; Drug Administration Schedule; Electroencephalography; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Signal Processing, Computer-Assisted	1992
A case of affective disorder associated with the misuse of 'anabolic steroids'. British journal of sports medicine, 1992, Volume: 26, Issue:4 Topics: Adult; Affective Disorders, Psychotic; Anabolic Agents; Antipsychotic Agents; Doping in Sports; Haloperidol; Humans; Male; Weight Lifting	1992
High incidence of haloperidol decanoate injection site reactions. The Journal of clinical psychiatry, 1992, Volume: 53, Issue:11 Topics: Dose-Response Relationship, Drug; Drug Eruptions; Erythema; Female; Haloperidol; Humans; Injections, Intramuscular	1992
Haloperidol decanoate pharmacokinetics in red blood cells and plasma. Journal of clinical psychopharmacology, 1992, Volume: 12, Issue:2 Topics: Adult; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Erythrocytes; Female; Haloperidol; Humans; Male; Metabolic Clearance Rate; Psychiatric Status Rating Scales; Psychotic Disorders	1992
Duration of neuroleptic treatment and relapse rate: a 5-year follow-up study with haloperidol decanoate. Clinical neuropharmacology, 1991, Volume: 14 Suppl 2 Topics: Antipsychotic Agents; Chronic Disease; Female; Follow-Up Studies; Haloperidol; Humans; Ireland; Male; Middle Aged; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology	1991
Effect of haloperidol decanoate on the cardiovascular system. The Japanese journal of psychiatry and neurology, 1991, Volume: 45, Issue:1 Topics: Adult; Antipsychotic Agents; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology	1991
Pharmacokinetics of haloperidol decanoate in rats. Journal of pharmacobio-dynamics, 1991, Volume: 14, Issue:11 Topics: Animals; Antipsychotic Agents; Haloperidol; Hydrolysis; Liver; Lymph Nodes; Male; Rats; Rats, Inbred Strains	1991
Haloperidol decanoate in chronic schizophrenia: a study of 12 months with plasma levels. Progress in neuro-psychopharmacology & biological psychiatry, 1990, Volume: 14, Issue:1 Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Recurrence; Schizophrenia	1990
Increases in rat striatal preproenkephalin mRNA levels following chronic treatment with the depot neuroleptic, haloperidol decanoate. Life sciences, 1990, Volume: 46, Issue:10 Topics: Animals; Antipsychotic Agents; Corpus Striatum; Delayed-Action Preparations; Enkephalins; Haloperidol; Male; Protein Biosynthesis; Protein Precursors; Rats; Rats, Inbred Strains; RNA, Messenger; Transcription, Genetic	1990
Injection site reactions after intramuscular administration of haloperidol decanoate 100 mg/mL. The Journal of clinical psychiatry, 1990, Volume: 51, Issue:12 Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Haloperidol; Humans; Hypersensitivity, Delayed; Injections, Intramuscular; Male; Skin; Skin Diseases	1990
High-performance liquid chromatographic analysis of haloperidol and hydroxyhaloperidol in plasma after solid-phase extraction. Journal of chromatography, 1990, Oct-26, Volume: 532, Issue:1 Topics: Chromatography, High Pressure Liquid; Haloperidol; Humans; Quality Control	1990
Neuroleptic-induced catatonia or a mild form of neuroleptic malignant syndrome? Neuropsychobiology, 1990, Volume: 23, Issue:1 Topics: Adult; Catatonia; Diagnosis, Differential; Haloperidol; Humans; Injections, Intramuscular; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders	1990
Methylazoxymethanol (MAM)-induced brain lesion and oral dyskinesia in rats. Psychopharmacology, 1990, Volume: 100, Issue:1 Topics: Animals; Azo Compounds; Behavior, Animal; Brain Diseases; Corpus Striatum; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Glutamate Decarboxylase; Haloperidol; Methylazoxymethanol Acetate; Pregnancy; Rats; Substantia Nigra	1990
Kinetics and clinical evaluation of haloperidol decanoate loading dose regimen. Psychopharmacology bulletin, 1990, Volume: 26, Issue:1 Topics: Adult; Female; Haloperidol; Humans; Male	1990
Pharmacokinetic properties of haloperidol decanoate. Activitas nervosa superior, 1989, Volume: 31, Issue:1 Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Haloperidol; Humans; Schizophrenia	1989
Haloperidol decanoate in the treatment of schizophrenia. Activitas nervosa superior, 1989, Volume: 31, Issue:1 Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Schizophrenia	1989
Haloperidol decanoate in the treatment of sexual deviations. Activitas nervosa superior, 1989, Volume: 31, Issue:1 Topics: Antipsychotic Agents; Double-Blind Method; Haloperidol; Humans; Sexual Dysfunctions, Psychological	1989
Haloperidol decanoate. The Australian and New Zealand journal of psychiatry, 1989, Volume: 23, Issue:3 Topics: Adult; Bipolar Disorder; Female; Haloperidol; Humans; Patient Compliance; Schizophrenia; Schizophrenic Psychology	1989
Effect of chronic administration of haloperidol (intermittently) and haloperidol-decanoate (continuously) on D2 dopamine and muscarinic cholinergic receptors and on carbachol-stimulated phosphoinositide hydrolysis in the rat striatum. The Japanese journal of psychiatry and neurology, 1987, Volume: 41, Issue:2 Topics: Animals; Binding Sites; Carbachol; Corpus Striatum; Haloperidol; Hippocampus; In Vitro Techniques; Norepinephrine; Phosphatidylinositols; Quinuclidinyl Benzilate; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Muscarinic; Spiperone	1987
Treatment of rapid cycling affective illness. The British journal of psychiatry : the journal of mental science, 1985, Volume: 146 Topics: Antipsychotic Agents; Bipolar Disorder; Haloperidol; Humans	1985
[Evaluation of the efficacy of haloperidol decanoate in the treatment of chronic psychotic hospital patients]. Acta psiquiatrica y psicologica de America latina, 1985, Volume: 31, Issue:1 Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Drug Evaluation; Female; Haloperidol; Humans; Inpatients; Middle Aged; Psychotic Disorders	1985
Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations. Acta psychiatrica Scandinavica. Supplementum, 1985, Volume: 322 Topics: Administration, Oral; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Haloperidol; Humans; Kinetics; Long-Term Care; Patient Compliance; Perphenazine; Schizophrenia; Schizophrenic Psychology; Thiazines	1985
Pharmacokinetics and therapeutic efficacy of haloperidol decanoate after loading dose administration. The British journal of psychiatry : the journal of mental science, 1986, Volume: 148 Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Kinetics; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders	1986
Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics. Clinical neuropharmacology, 1986, Volume: 9 Suppl 4 Topics: Administration, Oral; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Delayed-Action Preparations; Haloperidol; Humans; Maintenance; Schizophrenia	1986
Depot neuroleptics for acutely psychotic patients. The American journal of psychiatry, 1987, Volume: 144, Issue:8 Topics: Acute Disease; Antipsychotic Agents; Fluphenazine; Haloperidol; Humans; Psychotic Disorders	1987
Protracted neuroleptic malignant syndrome complicating long-acting neuroleptic administration. The American journal of medicine, 1988, Volume: 85, Issue:6 Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Enterocolitis, Pseudomembranous; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome	1988
Outcome of treatment with haloperidol decanoate in a patient with schizophrenia, chronic undifferentiated type, and end stage renal disease. Military medicine, 1988, Volume: 153, Issue:11 Topics: Adult; Antipsychotic Agents; Haloperidol; Humans; Kidney Failure, Chronic; Male; Schizophrenia	1988
Treatment of refractory Tourette syndrome with haloperidol decanoate. Acta psychiatrica Scandinavica, 1988, Volume: 77, Issue:4 Topics: Adult; Haloperidol; Humans; Male; Tourette Syndrome	1988
Haldol decanoate and thyroid disease. The Journal of clinical psychiatry, 1988, Volume: 49, Issue:11 Topics: Haloperidol; Humans; Nervous System Diseases; Thyrotoxicosis	1988
Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate. International clinical psychopharmacology, 1986, Volume: 1 Suppl 1 Topics: Animals; Delayed-Action Preparations; Dogs; Haloperidol; Humans; Schizophrenia	1986
The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate. International clinical psychopharmacology, 1986, Volume: 1 Suppl 1 Topics: Adult; Chronic Disease; Delayed-Action Preparations; Female; Haloperidol; Humans; Male; Schizophrenia	1986
Depot neuroleptics and manic depressive psychosis. International clinical psychopharmacology, 1986, Volume: 1 Suppl 1 Topics: Adolescent; Adult; Bipolar Disorder; Delayed-Action Preparations; Female; Haloperidol; Humans; Male; Middle Aged	1986
Violent and self-injurious behaviour in mentally handicapped patients--psychopharmacological control. International clinical psychopharmacology, 1986, Volume: 1 Suppl 1 Topics: Adult; Delayed-Action Preparations; Female; Haloperidol; Humans; Intellectual Disability; Male; Middle Aged; Self Mutilation; Violence	1986
Enzymatic hydrolysis of haloperidol decanoate and its inhibition by proteins. Biochemical pharmacology, 1987, May-15, Volume: 36, Issue:10 Topics: Animals; Carboxylesterase; Carboxylic Ester Hydrolases; Flufenamic Acid; Haloperidol; Humans; Hydrolysis; Kinetics; Lipoproteins, LDL; Male; Protein Binding; Proteins; Rats; Rats, Inbred Strains; Serum Albumin	1987
Excretion and metabolism of intramuscularly administered [14C]-haloperidol decanoate in rats. Arzneimittel-Forschung, 1986, Volume: 36, Issue:3 Topics: Animals; Bile; Carbon Radioisotopes; Enterohepatic Circulation; Feces; Haloperidol; Injections, Intramuscular; Injections, Intravenous; Male; Rats; Rats, Inbred Strains; Time Factors	1986
[Effect of haloperidol decanoate on the dopaminergic system in the rat brain]. Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology, 1986, Volume: 6, Issue:3 Topics: Animals; Brain; Corpus Striatum; Dopamine; Drug Tolerance; Frontal Lobe; Haloperidol; Injections, Intraperitoneal; Injections, Subcutaneous; Limbic System; Male; Rats; Rats, Inbred Strains	1986
Neuroleptic malignant syndrome: successful treatment with bromocriptine. Biological psychiatry, 1985, Volume: 20, Issue:6 Topics: Adolescent; Basal Ganglia Diseases; Bromocriptine; Creatine Kinase; Haloperidol; Homovanillic Acid; Humans; Male; Neuroleptic Malignant Syndrome; Paranoid Disorders; Prolactin; Transaminases	1985
Neuroendocrine effects of haloperidol decanoate in patients with chronic schizophrenia. Advances in biochemical psychopharmacology, 1985, Volume: 40 Topics: Adolescent; Adult; Chronic Disease; Drug Tolerance; Erectile Dysfunction; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Schizophrenia; Sex Factors; Sexual Dysfunction, Physiological; Time Factors	1985
Differential effects of haloperidol decanoate, a long-acting neuroleptic, in behavioral and biochemical tests. Archives internationales de pharmacodynamie et de therapie, 1985, Volume: 277, Issue:2 Topics: Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Biogenic Amines; Brain Chemistry; Corpus Striatum; Female; Haloperidol; Injections, Intramuscular; Injections, Intraventricular; Male; Mice; Prolactin; Rats; Rats, Inbred Strains; Spiperone; Time Factors	1985
Haloperidol decanoate: a depot neuroleptic. Drug and therapeutics bulletin, 1983, May-20, Volume: 21, Issue:10 Topics: Antipsychotic Agents; Haloperidol; Humans; Kinetics; Schizophrenia	1983
[Long-term therapy of chronic schizophrenic patients with haloperidol decanoate]. Psychiatrische Praxis, 1984, Volume: 11, Issue:2 Topics: Adolescent; Adult; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Haloperidol; Humans; Long-Term Care; Male; Schizophrenia; Schizophrenic Psychology	1984
Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. East African medical journal, 1984, Volume: 61, Issue:6 Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Delayed-Action Preparations; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Schizophrenia	1984
[Haloperidol decanoate. Results of an open-ended multicentric study in chronic psychotic states]. L'Encephale, 1984, Volume: 10, Issue:5 Topics: Adult; Delusions; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Psychotic Disorders; Schizophrenia	1984
[Neuroleptic-induced dopaminergic supersensitivity following intermittent and continuous haloperidol administrations in rats]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 1984, Volume: 86, Issue:10 Topics: Animals; Dyskinesia, Drug-Induced; Haloperidol; Male; Rats; Receptors, Dopamine	1984
Treatment of Gilles de la Tourette syndrome with depot neuroleptics. Acta neurologica, 1984, Volume: 6, Issue:3 Topics: Child; Delayed-Action Preparations; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Tourette Syndrome	1984
The use of depot neuroleptic haloperidol decanoate. Acta psychiatrica Scandinavica, 1984, Volume: 69, Issue:2 Topics: Bipolar Disorder; Depressive Disorder; Haloperidol; Humans; Prognosis; Psychotic Disorders; Schizophrenia	1984
Pharmacokinetics of haloperidol decanoate. A 2-year follow-up. International pharmacopsychiatry, 1982, Volume: 17, Issue:4 Topics: Chronic Disease; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Kinetics; Male; Schizophrenia	1982
12-month study of haloperidol decanoate in chronic schizophrenic patients. International pharmacopsychiatry, 1982, Volume: 17, Issue:4 Topics: Adult; Aged; Chronic Disease; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology	1982
Delusional electronic dental implant: case reports and literature review. The Journal of nervous and mental disease, 1995, Volume: 183, Issue:9 Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Delusions; Dental Implants; Drug Therapy, Combination; Electronics; Haloperidol; Humans; Lorazepam; Loxapine; Male; Middle Aged	1995
Clozapine in tardive Tourette syndrome. Biological psychiatry, 1995, Aug-01, Volume: 38, Issue:3 Topics: Adult; Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Haloperidol; Humans; Injections, Intramuscular; Male; Neurologic Examination; Schizophrenia; Schizophrenic Psychology; Social Behavior; Substance Withdrawal Syndrome; Tourette Syndrome	1995
How much haldol D does Larry really need? The Journal of clinical psychiatry, 1995, Volume: 56, Issue:7 Topics: Administration, Oral; Adult; Antipsychotic Agents; Drug Administration Schedule; Female; Haloperidol; Humans; Injections, Intramuscular; Psychotic Disorders	1995
Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate. Psychopharmacology, 1995, Volume: 118, Issue:2 Topics: Animals; Antipsychotic Agents; Catalepsy; Disease Models, Animal; Dyskinesia, Drug-Induced; Haloperidol; Male; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley	1995
Haloperidol decanoate: injection site reactions. The Journal of clinical psychiatry, 1995, Volume: 56, Issue:4 Topics: Antipsychotic Agents; Drug Eruptions; Haloperidol; Humans; Injections, Intramuscular	1995
Parallel development of dopamine metabolism tolerance in the rat prefrontal cortex, caudate-putamen, and amygdala following haloperidol decanoate administration. Biological psychiatry, 1995, Apr-01, Volume: 37, Issue:7 Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Antipsychotic Agents; Brain Mapping; Caudate Nucleus; Dopamine; Dose-Response Relationship, Drug; Drug Tolerance; Haloperidol; Homovanillic Acid; Male; Prefrontal Cortex; Putamen; Rats; Rats, Wistar	1995
Seasonal variation in the dexamethasone suppression test: a longitudinal study in chronic schizophrenics and in healthy subjects. Neuropsychobiology, 1994, Volume: 30, Issue:2-3 Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dexamethasone; Female; Haloperidol; Humans; Hydrocortisone; Longitudinal Studies; Male; Melatonin; Middle Aged; Psychiatric Status Rating Scales; Radioimmunoassay; Reference Values; Schizophrenia; Schizophrenic Psychology; Seasons	1994
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate. The American journal of psychiatry, 1995, Volume: 152, Issue:2 Topics: Adult; Ambulatory Care; Antipsychotic Agents; Basal Ganglia; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed	1995
Do enzyme inducers modify haloperidol decanoate rate of release? Progress in neuro-psychopharmacology & biological psychiatry, 1994, Volume: 18, Issue:8 Topics: Antipsychotic Agents; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Phenobarbital; Schizophrenia	1994
Neuroleptic effects on serine and glycine metabolism. Biological psychiatry, 1993, Oct-15, Volume: 34, Issue:8 Topics: Adult; Animals; Antipsychotic Agents; Brain; Cytosol; Female; Fluphenazine; Glycine; Glycine Hydroxymethyltransferase; Haloperidol; Humans; Liver; Male; Mitochondria, Liver; Psychiatric Status Rating Scales; Rabbits; Rats; Rats, Sprague-Dawley; Schizophrenia; Schizophrenic Psychology; Serine	1993
A loading-dose strategy for converting from oral to depot haloperidol. Hospital & community psychiatry, 1993, Volume: 44, Issue:12 Topics: Administration, Oral; Adult; Antipsychotic Agents; Chronic Disease; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Haloperidol; Humans; Injections, Intramuscular; Longitudinal Studies; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Retrospective Studies; Schizophrenia; Schizophrenic Psychology	1993
Quantitative EEG and BPRS data following Haldol-Decanoate administration in schizophrenics. International clinical psychopharmacology, 1994,Spring, Volume: 9, Issue:1 Topics: Adult; Alpha Rhythm; Antipsychotic Agents; Cerebral Cortex; Delayed-Action Preparations; Electroencephalography; Female; Fourier Analysis; Haloperidol; Humans; Male; Middle Aged; Prognosis; Psychiatric Status Rating Scales; Schizophrenia, Paranoid; Signal Processing, Computer-Assisted; Synaptic Transmission	1994
Comparative study of dopamine metabolism with local cerebral glucose utilization in rat brain following the administration of haloperidol decanoate. Biological psychiatry, 1994, Jul-15, Volume: 36, Issue:2 Topics: Animals; Antipsychotic Agents; Blood Glucose; Brain; Brain Mapping; Dopamine; Haloperidol; Injections, Intramuscular; Male; Rats; Rats, Wistar	1994
A single injection of either flupenthixol decanoate or haloperidol decanoate produces long-term changes in cocaine self-administration in rats. Drug and alcohol dependence, 1994, Volume: 36, Issue:1 Topics: Animals; Cocaine; Flupenthixol; Haloperidol; Injections, Intramuscular; Male; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Substance-Related Disorders; Tranquilizing Agents	1994
[Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses]. Ceskoslovenska psychiatrie, 1993, Volume: 89, Issue:1 Topics: Adult; Antipsychotic Agents; Dibenzothiepins; Female; Haloperidol; Humans; Male; Schizophrenia	1993
Haloperidol decanoate (Janssen) in the treatment of sexual deviations. Ceskoslovenska psychiatrie, 1993, Volume: 89, Issue:1 Topics: Adult; Antipsychotic Agents; Haloperidol; Humans; Male; Paraphilic Disorders	1993
Haloperidol decanoate (Janssen) in the treatment of schizophrenia. Ceskoslovenska psychiatrie, 1993, Volume: 89, Issue:1 Topics: Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Male; Schizophrenia	1993
EEG- and EP-mapping--possible indicators for disturbed information processing in schizophrenia? Progress in neuro-psychopharmacology & biological psychiatry, 1993, Volume: 17, Issue:4 Topics: Adult; Antipsychotic Agents; Brain Mapping; Electroencephalography; Evoked Potentials, Auditory; Haloperidol; Humans; Mental Processes; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1993
3H-spiroperidol binding to peripheral mononuclear cells in schizophrenic and healthy subjects. Biological psychiatry, 1993, May-15, Volume: 33, Issue:10 Topics: Adult; Binding, Competitive; Clozapine; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Radioligand Assay; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology; Spiperone	1993
Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenics. Progress in neuro-psychopharmacology & biological psychiatry, 1993, Volume: 17, Issue:1 Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Female; Haloperidol; Humans; Male; Middle Aged; Regression Analysis; Schizophrenia	1993
Chronic antagonist treatment does not alter the mode of interaction of dopamine with rat striatal dopamine receptors. Journal of receptor research, 1993, Volume: 13, Issue:1-4 Topics: Animals; Benzazepines; Binding, Competitive; Corpus Striatum; Dopamine; Dopamine Antagonists; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Time Factors	1993
Prolonged haloperidol and reduced haloperidol plasma concentrations after decanoate withdrawal. Schizophrenia research, 1993, Volume: 9, Issue:1 Topics: Adult; Female; Half-Life; Haloperidol; Humans; Injections, Intramuscular; Male; Metabolic Clearance Rate; Middle Aged; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome	1993
Effects of haloperidol decanoate on plasma homovanillic acid in chronic schizophrenic patients. Biological psychiatry, 1993, Apr-01, Volume: 33, Issue:7 Topics: Adult; Brain; Chronic Disease; Delayed-Action Preparations; Female; Haloperidol; Homovanillic Acid; Humans; Middle Aged; Schizophrenia; Schizophrenic Psychology	1993
[Accidental intravenous administration of haloperidol decanoate]. Psychiatrische Praxis, 1996, Volume: 23, Issue:1 Topics: Adult; Antipsychotic Agents; Crisis Intervention; Female; Haloperidol; Humans; Injections, Intravenous; Medication Errors; Patient Care Team; Personality Disorders; Tachycardia, Sinus	1996
Haloperidol and reduced haloperidol plasma concentrations after a loading dose regimen with haloperidol decanoate. Progress in neuro-psychopharmacology & biological psychiatry, 1996, Volume: 20, Issue:1 Topics: Adult; Antipsychotic Agents; Female; Haloperidol; Humans; Male; Middle Aged; Schizophrenia	1996
Large variations of plasma levels during maintenance treatment with depot neuroleptics. The British journal of psychiatry : the journal of mental science, 1996, Volume: 169, Issue:5 Topics: Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Drug Monitoring; Female; Flupenthixol; Follow-Up Studies; Haloperidol; Humans; Injections, Intramuscular; Long-Term Care; Male; Middle Aged; Neurologic Examination; Perphenazine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1996
[Rhabdomyolysis and acute renal failure caused by haloperidol-decanoate (neuroleptic malignant syndrome)]. Recenti progressi in medicina, 1996, Volume: 87, Issue:9 Topics: Acute Kidney Injury; Antipsychotic Agents; Haloperidol; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Rhabdomyolysis	1996
Morphological changes in met(5)-enkephalin-immunoreactive synaptic boutons in the rat neostriatum after haloperidol decanoate treatment. The European journal of neuroscience, 1996, Volume: 8, Issue:4 Topics: Animals; Corpus Striatum; Dendrites; Enkephalin, Methionine; Haloperidol; Immune Sera; Male; Microscopy, Electron; Rats; Rats, Wistar; Synapses	1996
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine. Psychiatric services (Washington, D.C.), 1997, Volume: 48, Issue:1 Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Schizophrenia	1997
Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings. Archives of general psychiatry, 1997, Volume: 54, Issue:10 Topics: Adult; Antipsychotic Agents; Basal Ganglia; Brain; Delayed-Action Preparations; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Mathematics; Middle Aged; Putamen; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Tomography, Emission-Computed	1997
Comparison of two high-performance liquid chromatographic methods for monitoring plasma concentrations of haloperidol and reduced haloperidol. Therapeutic drug monitoring, 1998, Volume: 20, Issue:2 Topics: Administration, Oral; Adult; Antipsychotic Agents; Calibration; Chromatography, High Pressure Liquid; Drug Interactions; Drug Monitoring; Electrochemistry; Haloperidol; Humans; Injections, Intravenous; Linear Models; Male; Mental Disorders; Middle Aged; Oxidation-Reduction; Polypharmacy; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet	1998
Expression of Fos protein in the limbic regions of the rat following haloperidol decanoate. Brain research, 1998, Apr-27, Volume: 791, Issue:1-2 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Catalepsy; Haloperidol; Immunohistochemistry; Limbic System; Male; Nerve Tissue Proteins; Neurons; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar	1998
Dopamine D2-receptor density in humans as assessed with SPET and the new high-affinity ligand 123I-NCQ298: a pilot study. Nuclear medicine communications, 1998, Volume: 19, Issue:3 Topics: Adult; Aged; Antipsychotic Agents; Brain; Cerebrovascular Circulation; Dopamine Agonists; Female; Haloperidol; Humans; Iodine Radioisotopes; Male; Middle Aged; Perphenazine; Pilot Projects; Radiopharmaceuticals; Receptors, Dopamine D2; Regional Blood Flow; Salicylamides; Schizophrenia; Tissue Distribution; Tomography, Emission-Computed, Single-Photon	1998
Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia. Brain research, 1998, Jun-15, Volume: 796, Issue:1-2 Topics: Animals; Antipsychotic Agents; Corpus Striatum; Dizocilpine Maleate; Down-Regulation; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Haloperidol; Male; Mastication; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission	1998
Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: comparison with risperidone. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Dec-15, Volume: 55, Issue:24 Suppl 4 Topics: Antipsychotic Agents; Baltimore; Chronic Disease; Delayed-Action Preparations; Disease-Free Survival; Female; Fluphenazine; Haloperidol; Humans; Length of Stay; Male; Patient Readmission; Risperidone; Schizophrenia; Time Factors	1998
Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients. Therapeutic drug monitoring, 1999, Volume: 21, Issue:5 Topics: Adult; Aged; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Enzyme Induction; Enzyme Inhibitors; Genotype; Haloperidol; Humans; Inpatients; Middle Aged; Polymorphism, Genetic; Polypharmacy; Schizophrenia; Smoking	1999
Haloperidol decanoate in children. Journal of the American Academy of Child and Adolescent Psychiatry, 2001, Volume: 40, Issue:8 Topics: Administration, Oral; Antipsychotic Agents; Child; Child Behavior Disorders; Child Development Disorders, Pervasive; Haloperidol; Humans; Injections, Intramuscular; Male; Patient Compliance; Treatment Outcome	2001
Outcome comparison of patients receiving oral or depot neuroleptic medication. Psychological reports, 2001, Volume: 89, Issue:1 Topics: Administration, Oral; Adult; Antipsychotic Agents; Chronic Disease; Cohort Studies; Delayed-Action Preparations; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia	2001
Tardive dyskinesia model in the common marmoset. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:2 Topics: Animals; Biperiden; Callithrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Female; Haloperidol; Male; Neurologic Examination; Parkinsonian Disorders	2002
The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders. International journal of geriatric psychiatry, 2002, Volume: 17, Issue:11 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prodrugs; Psychotic Disorders; Schizophrenia	2002
The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats. Psychopharmacology, 2003, Volume: 165, Issue:2 Topics: Animals; Antipsychotic Agents; Cerebellum; Corpus Striatum; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Haloperidol; Male; Mastication; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior	2003
Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003, Jul-16, Volume: 23, Issue:15 Topics: Adult; Aged; Animals; Autoradiography; Benztropine; Calbindin 2; Cell Count; Female; gamma-Aminobutyric Acid; Gene Expression Profiling; Glutamate Decarboxylase; Haloperidol; Humans; In Situ Hybridization; Isoenzymes; Macaca fascicularis; Male; Middle Aged; Neural Inhibition; Neurons; Oligonucleotide Array Sequence Analysis; Parvalbumins; Prefrontal Cortex; RNA, Messenger; S100 Calcium Binding Protein G; Schizophrenia; Substrate Specificity; Synaptic Transmission; Time	2003
Differential effects of antipsychotics on haloperidol-induced vacuous chewing movements and subcortical gene expression in the rat. European journal of pharmacology, 2003, Sep-12, Volume: 477, Issue:2 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Dyskinesia, Drug-Induced; Gene Expression; Haloperidol; In Situ Hybridization; Injections, Intramuscular; Male; Mastication; Olanzapine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate; RNA, Messenger	2003
Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats. Neuroscience, 2003, Volume: 122, Issue:3 Topics: Aging; Analysis of Variance; Animals; Behavior, Animal; Cell Count; Disease Models, Animal; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Haloperidol; Mastication; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substantia Nigra; Time; Time Factors	2003
Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice. Endocrinology, 2005, Volume: 146, Issue:7 Topics: Animals; Cell Proliferation; Cells, Cultured; Culture Media, Conditioned; Dopamine Antagonists; Estrogens; Female; Haloperidol; Humans; Hyperplasia; Mice; Mice, Knockout; Pituitary Gland; Prolactin; Receptors, Dopamine D2; RNA, Messenger; Tissue Distribution; Umbilical Veins; Vascular Endothelial Growth Factor A	2005
Long term results of unilateral posteroventral pallidotomy for antipsychotic drug induced tardive dyskinesia. Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:7 Topics: Athetosis; Chorea; Clopenthixol; Delayed-Action Preparations; Dominance, Cerebral; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Follow-Up Studies; Globus Pallidus; Haloperidol; Humans; Male; Middle Aged; Myoclonus; Neurologic Examination; Outcome Assessment, Health Care; Schizophrenia; Treatment Outcome	2005
Methodological issues in a study of long-term maintenance therapy with quetiapine versus haloperidol decanoate. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:3 Topics: Administration, Oral; Antipsychotic Agents; Dibenzothiazepines; Drug Administration Schedule; Haloperidol; Humans; Injections; Psychotic Disorders; Quetiapine Fumarate; Research Design; Sample Size; Schizophrenia; Treatment Outcome	2006
Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia. Psychiatric services (Washington, D.C.), 2007, Volume: 58, Issue:4 Topics: Administration, Oral; Adult; Alcoholism; Antipsychotic Agents; Black People; Cohort Studies; Comorbidity; Crime; Cross-Sectional Studies; Delayed-Action Preparations; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Illicit Drugs; Male; Middle Aged; Patient Readmission; Prospective Studies; Schizophrenia; Schizophrenia, Disorganized; Schizophrenic Psychology; Substance-Related Disorders; Treatment Outcome; United States; White People	2007
Glycine stimulates the release of labeled acetylcholine but not dopamine nor glutamate from superfused rat striatal tissue. Brain research, 2007, Sep-07, Volume: 1168 Topics: Acetylcholine; Analysis of Variance; Animals; Antipsychotic Agents; Calcium; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Glutamic Acid; Glycine; Glycine Agents; Haloperidol; In Vitro Techniques; Male; N-Methylaspartate; Rats; Rats, Wistar; Sodium Channel Blockers; Tetrodotoxin; Time Factors; Tritium	2007
Resolution of haloperidol-induced hyperprolactinemia with aripiprazole. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5 Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clonazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gynecomastia; Haloperidol; Humans; Hyperprolactinemia; Male; Piperazines; Prolactin; Quinolones; Valproic Acid	2007
Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot. Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:5 Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Middle Aged; Piperazines; Quinolones; Remission Induction; Schizophrenia; Substance-Related Disorders	2007
Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo. Neurobiology of disease, 2008, Volume: 29, Issue:1 Topics: Age Factors; Animals; Antipsychotic Agents; Cell Count; Corpus Striatum; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Female; Gene Expression Regulation; Haloperidol; Huntingtin Protein; Huntington Disease; Lentivirus; Mutation; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Phosphopyruvate Hydratase; Rats; Rats, Wistar	2008
[Mental patients and their profile of compliance with psychopharmacological treatment]. Revista da Escola de Enfermagem da U S P, 2009, Volume: 43, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Cross-Sectional Studies; Female; Haloperidol; Humans; Male; Mental Disorders; Middle Aged; Patient Compliance; Retrospective Studies; Young Adult	2009
Effects of omega-3 essential fatty acids (omega-3 EFAs) on motor disorders and memory dysfunction typical neuroleptic-induced: behavioral and biochemical parameter. Neurotoxicity research, 2010, Volume: 17, Issue:3 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Disease Models, Animal; Dyskinesia, Drug-Induced; Fatty Acids, Omega-3; Haloperidol; Male; Maze Learning; Memory Disorders; Movement Disorders; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Time Factors	2010
Antipsychotic-induced gene regulation in multiple brain regions. Journal of neurochemistry, 2010, Volume: 113, Issue:1 Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Gene Expression Profiling; Gene Expression Regulation; Haloperidol; Male; Neurotransmitter Agents; Olanzapine; Oligonucleotide Array Sequence Analysis; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Signal Transduction; Transcription Factors	2010
Psychosis following excessive ingestion of energy drinks in a patient with schizophrenia. The American journal of psychiatry, 2010, Volume: 167, Issue:3 Topics: Adult; Affect; Antipsychotic Agents; Arousal; Beverages; Caffeine; Central Nervous System Stimulants; Disease Progression; Dose-Response Relationship, Drug; Haloperidol; Humans; Injections, Intramuscular; Male; Psychoses, Substance-Induced; Schizophrenia, Paranoid	2010
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities. Schizophrenia research, 2010, Volume: 119, Issue:1-3 Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Length of Stay; Male; Microspheres; Middle Aged; Patient Discharge; Proportional Hazards Models; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome	2010
Case report: increased patient response to intramuscular haloperidol decanoate following a change in needle length. Journal of pharmacy practice, 2011, Volume: 24, Issue:6 Topics: Antipsychotic Agents; Biological Availability; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Injections, Intramuscular; Needles; Schizophrenia; Treatment Outcome; Young Adult	2011
Alopecia areata associated with haloperidol decanoate long-acting injection. The Australian and New Zealand journal of psychiatry, 2012, Volume: 46, Issue:1 Topics: Adult; Alopecia Areata; Antipsychotic Agents; Delayed-Action Preparations; Haloperidol; Humans; Male	2012
Upregulation of cornichon transcripts in the dorsolateral prefrontal cortex in schizophrenia. Neuroreport, 2012, Dec-05, Volume: 23, Issue:17 Topics: Aged; Aged, 80 and over; Animals; Antipsychotic Agents; Egg Proteins; Female; Frontal Lobe; Gene Expression Regulation; Genetic Markers; Genetic Predisposition to Disease; Glutamic Acid; Haloperidol; Humans; Male; Membrane Proteins; Middle Aged; Nerve Tissue Proteins; Prefrontal Cortex; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, AMPA; RNA, Messenger; Schizophrenia; Synaptic Transmission; Up-Regulation	2012
[Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics]. L'Encephale, 2013, Volume: 39 Suppl 1 Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Movement Disorders; Neurologic Examination; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Surveys and Questionnaires; Tunisia	2013
Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review. International clinical psychopharmacology, 2013, Volume: 28, Issue:5 Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Drug Combinations; Female; Fluphenazine; Haloperidol; Humans; International Classification of Diseases; Longitudinal Studies; Maintenance Chemotherapy; Male; Medical Records; Medication Adherence; Middle Aged; Retrospective Studies; Schizophrenia; Secondary Prevention; Treatment Outcome	2013
Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate. Psychiatry research, 2013, Dec-30, Volume: 210, Issue:3 Topics: Adult; Antioxidants; Antipsychotic Agents; Basal Ganglia Diseases; Catalase; Female; Glutathione; Glutathione Peroxidase; Haloperidol; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Psychopathology; Schizophrenia; Severity of Illness Index; Superoxide Dismutase	2013
Barriers to utilizing long-acting injectable antipsychotic medications. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2013, Volume: 25, Issue:4 Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Haloperidol; Humans; Injections; Michigan; Physicians; Practice Patterns, Physicians'; Psychiatry	2013
Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden. Nordic journal of psychiatry, 2014, Volume: 68, Issue:6 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost of Illness; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Costs; Female; Haloperidol; Health Care Costs; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Models, Econometric; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Sweden	2014
Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophrenia. Schizophrenia research, 2014, Volume: 154, Issue:1-3 Topics: Aged; Animals; Antipsychotic Agents; Blotting, Western; Down-Regulation; Female; Haloperidol; Humans; Intracellular Signaling Peptides and Proteins; Isomerism; Male; Membrane Proteins; Myristoylated Alanine-Rich C Kinase Substrate; Neoplasm Proteins; Phosphorylation; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Schizophrenia	2014
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats. Progress in neuro-psychopharmacology & biological psychiatry, 2014, Oct-03, Volume: 54 Topics: Animals; Antipsychotic Agents; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Endocannabinoids; Haloperidol; Male; Mastication; Movement; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Treatment Outcome	2014
Maintenance treatment with long-acting injectable antipsychotics: comparing old with new. JAMA, 2014, May-21, Volume: 311, Issue:19 Topics: Antipsychotic Agents; Female; Haloperidol; Humans; Isoxazoles; Male; Paliperidone Palmitate; Palmitates	2014
Adjusting Treatment for an Inmate-Patient Receiving Medication Involuntarily. The journal of the American Academy of Psychiatry and the Law, 2015, Volume: 43, Issue:2 Topics: Adult; Antipsychotic Agents; Coercion; Commitment of Mentally Ill; Dangerous Behavior; Delayed-Action Preparations; Expert Testimony; Forensic Psychiatry; Guideline Adherence; Haloperidol; Humans; Injections, Intramuscular; Male; Mental Competency; Physician's Role; Prisoners; Schizophrenia, Paranoid; Treatment Refusal	2015
Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia. Schizophrenia research, 2015, Volume: 166, Issue:1-3 Topics: Aged; Animals; Antipsychotic Agents; Blotting, Western; Female; Gray Matter; Haloperidol; Humans; Male; N-Acetylglucosaminyltransferases; Prefrontal Cortex; Rats, Sprague-Dawley; Schizophrenia	2015
Drug-induced parkinsonism following chronic methamphetamine use by a patient on haloperidol decanoate. International journal of psychiatry in medicine, 2015, Volume: 50, Issue:4 Topics: Adult; Amphetamine-Related Disorders; Diphenhydramine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Injections, Intramuscular; Male; Methamphetamine; Neural Pathways; Nucleus Accumbens; Parkinson Disease, Secondary; Patient Admission; Patient Readmission; Psychotic Disorders; Receptors, Dopamine D2; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Substantia Nigra; Treatment Refusal	2015
Multiple Long-Acting Injectable Antipsychotics for Treatment-Resistant Schizophrenia: Case Report. Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:3 Topics: Adult; Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Drug Therapy, Combination; Haloperidol; Humans; Injections, Intramuscular; Male; Olanzapine; Schizophrenia	2016
Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: A retrospective database study. PloS one, 2017, Volume: 12, Issue:6 Topics: Adult; Antipsychotic Agents; Belgium; Benzodiazepines; Delayed-Action Preparations; Drug Administration Schedule; Female; Haloperidol; Humans; Medication Adherence; Netherlands; Olanzapine; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia; Treatment Outcome	2017
An acute oral intoxication with haloperidol decanoate. The American journal of emergency medicine, 2017, Volume: 35, Issue:9 Topics: Administration, Oral; Antipsychotic Agents; Arrhythmias, Cardiac; Charcoal; Electrocardiography; Female; Haloperidol; Humans; Laxatives; Male; Schizophrenia; Young Adult	2017
Risperidone-associated sinus tachycardia potentiated by paliperidone palmitate in a patient with no prior cardiovascular disease: role of risperidone-related autonomic instability. BMJ case reports, 2018, Apr-21, Volume: 2018 Topics: Antipsychotic Agents; Autonomic Nervous System; Cardiovascular Diseases; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Humans; Male; Paliperidone Palmitate; Risperidone; Schizophrenia; Tachycardia, Sinus; Treatment Outcome; Young Adult	2018
Real-life persistence of long-acting injectable antipsychotics in schizophrenic patients: A retrospective observational study in France . International journal of clinical pharmacology and therapeutics, 2019, Volume: 57, Issue:9 Topics: Antipsychotic Agents; Delayed-Action Preparations; France; Haloperidol; Humans; Injections; Paliperidone Palmitate; Retrospective Studies; Risperidone; Schizophrenia	2019
Neuroleptic malignant syndrome in a COVID-19 patient. Brain, behavior, and immunity, 2020, Volume: 88 Topics: Acute Kidney Injury; Antipsychotic Agents; Betacoronavirus; Bromocriptine; C-Reactive Protein; Coronavirus Infections; COVID-19; Dantrolene; Dopamine Agonists; Enzyme Inhibitors; Haloperidol; Humans; Hydroxychloroquine; Intensive Care Units; Leukocytosis; Lymphopenia; Male; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Pandemics; Pneumonia, Viral; Renal Dialysis; Respiration, Artificial; Rhabdomyolysis; SARS-CoV-2; Schizophrenia	2020
Improved Treatment Outcome with Haloperidol Decanoate and Amantadine in an Adolescent with Schizoaffective Disorder. Journal of child and adolescent psychopharmacology, 2023, Volume: 33, Issue:8 Topics: Adolescent; Amantadine; Antipsychotic Agents; Haloperidol; Humans; Psychotic Disorders; Treatment Outcome	2023